SAT0145 Efficacy and Safety of Sirukumab in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of A Randomized, Double-Blind, Placebo-Controlled Study: Table 1.

Controlled Study ◽

Efficacy And Safety ◽

Treatment Results ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment (Sirround-D)

Value in Health ◽

10.1016/j.jval.2016.09.1074 ◽

2016 ◽

Vol 19 (7) ◽

pp. A531 ◽

Cited By ~ 2

Author(s):

T Takeuchi ◽

C Thorne ◽

G Karpouzas ◽

S Sheng ◽

W Xu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

Arthritis & Rheumatism ◽

10.1002/art.21778 ◽

2006 ◽

Vol 54 (5) ◽

pp. 1390-1400 ◽

Cited By ~ 682

Author(s):

Paul Emery ◽

Roy Fleischmann ◽

Anna Filipowicz-Sosnowska ◽

Joy Schechtman ◽

Leszek Szczepanski ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Treatment Results ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging ◽

Methotrexate Treatment

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy

SpringerPlus ◽

10.1186/s40064-015-0895-9 ◽

2015 ◽

Vol 4 (1) ◽

Cited By ~ 10

Author(s):

Kathryn Hobbs ◽

Atul Deodhar ◽

Brian Wang ◽

Bojena Bitman ◽

Joyce Nussbaum ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Dmard Therapy ◽

SAT0166 An Analysis of Laboratory Results from 2 Randomized, Double-Blind Studies of Sirukumab in Patients with Active Rheumatoid Arthritis Refractory To Disease-Modifying Anti-Rheumatic Drug Treatment: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.4126 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 726.2-727

Author(s):

G. Karpouzas ◽

C. Thorne ◽

T. Takeuchi ◽

Y. Tanaka ◽

H. Yamanaka ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Treatment ◽

Double Blind ◽

Laboratory Results ◽

Disease Modifying ◽

Treatment Table ◽

A multicentre randomised double blind placebo controlled study comparing two regimens of combination induction therapy in early disease-modifying anti-rheumatic drug naïve rheumatoid arthritis

http://isrctn.org/> ◽

10.1186/isrctn48638981 ◽

2013 ◽

Author(s):

Paul Emery

Keyword(s):

Rheumatoid Arthritis ◽

Induction Therapy ◽

Controlled Study ◽

Early Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Drug Naïve ◽

Disease Modifying ◽

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial

Trials ◽

10.1186/s13063-018-2849-3 ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 2

Author(s):

Seunghoon Lee ◽

Yeeun Cho ◽

Jihye Kim ◽

Jung Won Kang ◽

Ga Young Yoon ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Herbal Medicine ◽

Study Protocol ◽

Pilot Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study

The Journal of Rheumatology ◽

10.3899/jrheum.150613.c1 ◽

2016 ◽

Vol 43 (5) ◽

pp. 998-998

Keyword(s):

Rheumatoid Arthritis ◽

Japanese Patients ◽

Methotrexate Therapy ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Efficacy and Safety of Ketoprofen Patch in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Study

The Journal of Clinical Pharmacology ◽

10.1177/0091270009355813 ◽

2010 ◽

Vol 50 (10) ◽

pp. 1171-1179 ◽

Cited By ~ 4

Author(s):

Shinichi Kawai ◽

Eiji Uchida ◽

Masakazu Kondo ◽

Syuji Ohno ◽

Junichi Obata ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis - a double blind placebo controlled study

Inflammation Research ◽

10.1007/pl00000240 ◽

2001 ◽

Vol 50 (12) ◽

pp. 598-601 ◽

Cited By ~ 8

Author(s):

H. Valleala ◽

K. Laitinen ◽

L. Pylkkänen ◽

Y.T. Konttinen ◽

C. Friman

Keyword(s):

Rheumatoid Arthritis ◽

Biochemical Response ◽

Controlled Study ◽

Single Infusion ◽

Double Blind ◽